Zakrzewski, P.K.; Forma, E.; Cygankiewicz, A.I.; Bryś, M.; Wójcik-Krowiranda, K.; Bieńkiewicz, A.; Semczuk, A.; Krajewska, W.M.
Betaglycan Gene (TGFBR3) Polymorphism Is Associated with Increased Risk of Endometrial Cancer. J. Clin. Med. 2020, 9, 3082.
https://doi.org/10.3390/jcm9103082
AMA Style
Zakrzewski PK, Forma E, Cygankiewicz AI, Bryś M, Wójcik-Krowiranda K, Bieńkiewicz A, Semczuk A, Krajewska WM.
Betaglycan Gene (TGFBR3) Polymorphism Is Associated with Increased Risk of Endometrial Cancer. Journal of Clinical Medicine. 2020; 9(10):3082.
https://doi.org/10.3390/jcm9103082
Chicago/Turabian Style
Zakrzewski, Piotr K., Ewa Forma, Adam I. Cygankiewicz, Magdalena Bryś, Katarzyna Wójcik-Krowiranda, Andrzej Bieńkiewicz, Andrzej Semczuk, and Wanda M. Krajewska.
2020. "Betaglycan Gene (TGFBR3) Polymorphism Is Associated with Increased Risk of Endometrial Cancer" Journal of Clinical Medicine 9, no. 10: 3082.
https://doi.org/10.3390/jcm9103082
APA Style
Zakrzewski, P. K., Forma, E., Cygankiewicz, A. I., Bryś, M., Wójcik-Krowiranda, K., Bieńkiewicz, A., Semczuk, A., & Krajewska, W. M.
(2020). Betaglycan Gene (TGFBR3) Polymorphism Is Associated with Increased Risk of Endometrial Cancer. Journal of Clinical Medicine, 9(10), 3082.
https://doi.org/10.3390/jcm9103082
